Biophytis Sa Stock Fundamentals
| ALBPS Stock | EUR 0.30 0.01 3.45% |
Biophytis SA fundamentals help investors to digest information that contributes to Biophytis' financial success or failures. It also enables traders to predict the movement of Biophytis Stock. The fundamental analysis module provides a way to measure Biophytis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biophytis stock.
Biophytis |
Biophytis SA Company Shares Owned By Institutions Analysis
Biophytis' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Biophytis Shares Owned By Institutions | 0.25 % |
Most of Biophytis' fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biophytis SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.25% of Biophytis SA are shares owned by institutions. This is 99.44% lower than that of the Biotechnology sector and 99.47% lower than that of the Health Care industry. The shares owned by institutions for all France stocks is 99.36% higher than that of the company.
Biophytis SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biophytis's current stock value. Our valuation model uses many indicators to compare Biophytis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biophytis competition to find correlations between indicators driving Biophytis's intrinsic value. More Info.Biophytis SA is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biophytis' earnings, one of the primary drivers of an investment's value.Biophytis Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biophytis' direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics of similar companies.Biophytis is currently under evaluation in shares owned by institutions category among its peers.
Biophytis Fundamentals
| Return On Equity | -6.81 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (498.56 K) | |||
| Shares Outstanding | 203.97 M | |||
| Shares Owned By Institutions | 0.25 % | |||
| Price To Earning | (4.45) X | |||
| Price To Book | 1.62 X | |||
| EBITDA | (26.5 M) | |||
| Net Income | (31.25 M) | |||
| Cash And Equivalents | 7 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 6.29 M | |||
| Debt To Equity | 442.80 % | |||
| Current Ratio | 1.80 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (23.8 M) | |||
| Earnings Per Share | (0.19) X | |||
| Target Price | 0.1 | |||
| Number Of Employees | 26 | |||
| Beta | 1.19 | |||
| Market Capitalization | 8.24 M | |||
| Total Asset | 36.26 M | |||
| Z Score | 0.6 | |||
| Net Asset | 36.26 M |
About Biophytis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biophytis SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was founded in 2006 and is headquartered in Paris, France. BIOPHYTIS operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 30 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biophytis Stock Analysis
When running Biophytis' price analysis, check to measure Biophytis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biophytis is operating at the current time. Most of Biophytis' value examination focuses on studying past and present price action to predict the probability of Biophytis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biophytis' price. Additionally, you may evaluate how the addition of Biophytis to your portfolios can decrease your overall portfolio volatility.